Hepatitis C virus: Management of recurrent disease
Elizabeth C. Verna – 19 August 2013 – Watch a video presentation of this article
Hepatitis C virus: Management of recurrent disease
Elizabeth C. Verna – 19 August 2013 – Watch a video presentation of this article
Expanding the donor pool in liver transplantation: Extended criteria donors
Andrew S. deLemos, Parsia A. Vagefi – 19 August 2013 – Watch a video presentation of this article
Common problems in liver allograft biopsy interpretation: Resolving clinical dilemmas
Oyedele A. Adeyi – 19 August 2013 – Watch a video presentation of this article
Selection for liver transplantation
Adam Peyton, Paul Martin – 19 August 2013 – Watch a video presentation of this article
Immunosuppression: Conventions and controversies
Neil Mehta, Ryutaro Hirose – 19 August 2013 – Watch a video presentation of this article
Donor and recipient effects on graft and patient survival
JP Norvell, Josh Levitsky – 19 August 2013 – Watch a video presentation of this article
Acute liver failure: Peritransplant management and outcomes
Oren K. Fix – 19 August 2013 – Watch a video presentation of this article
Hepatitis B virus: Prevention of recurrent infection
Federico G. Villamil, Fernando M. Cairo – 19 August 2013 – Watch a video presentation of this article
Human CD14+CTLA‐4+ regulatory dendritic cells suppress T‐cell response by cytotoxic T‐lymphocyte antigen‐4‐dependent IL‐10 and indoleamine‐2,3‐dioxygenase production in hepatocellular carcinoma
Yanmei Han, Zhubo Chen, Yuan Yang, Zhengping Jiang, Yan Gu, Yangfang Liu, Chuan Lin, Zeya Pan, Yizhi Yu, Minghong Jiang, Weiping Zhou, Xuetao Cao – 19 August 2013 – Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. HCC‐induced immunosuppression often leads to ineffectiveness of immuno‐promoting therapies. Currently, suppressing the suppressors has become the potential strategy for cancer immunotherapy.